Managers / Q1 2026
McBroom & Associates, LLC
CIK 0001908893 · 1635 VILLAGE CENTER CIRCLE, SUITE 140, LAS VEGAS, NV, 89134 · (702) 267-6649
Summary
Mcbroom & Associates, LLC reported $180M in U.S.-listed holdings across 36 positions for Q1 2026.
Its largest position, NVDA, represents 8.8% of the portfolio.
Compared with Q4 2025, the fund opened 0 new positions and exited 2.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 89.1% · $160M
- ETP · 10.9% · $20M
Quarter-over-Quarter Changes full breakdown →
vs Q4 2025 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| CPRTCOPART INC | SOLD OUT | −127.7K | 0 | −$5M | $0 |
| SCHWAB STRATEGIC TR | SOLD OUT | −13.3K | 0 | −$324,024 | $0 |
| CALMCAL MAINE FOODS INC | ADDED | +4.0K | 8.9K | +$315,901 | $703,327 |
| SFMSPROUTS FMRS MKT INC | ADDED | +16.6K | 38.6K | +$1M | $3M |
| ISHARES TR | ADDED | +30.8K | 108.5K | +$1M | $4M |
| ZTSZOETIS INC | TRIMMED | −2.0K | 5.8K | −$297,897 | $689,715 |
| LRCXLAM RESEARCH CORP | TRIMMED | −19.2K | 63.4K | −$594,117 | $14M |
| J P MORGAN EXCHANGE TRADED F | TRIMMED | −6.2K | 27.0K | −$311,449 | $1M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2026
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $180M | 36 | Apr 23, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $206M | 38 | Jan 20, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $210M | 37 | Oct 29, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $175M | 37 | Aug 5, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $175M | 37 | Apr 17, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $177M | 35 | Jan 29, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $163M | 34 | Oct 18, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $160M | 33 | Aug 7, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $152M | 33 | Apr 16, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $137M | 33 | Jan 8, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $126M | 36 | Oct 16, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $127M | 37 | Jul 24, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $112M | 36 | Apr 21, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $92M | 35 | Jan 26, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $89M | 35 | Oct 27, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $92M | 29 | Jul 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $113M | 28 | May 4, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $133M | 30 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.